Kiniksa Pharmaceuticals, Ltd. (KNSA)
USD 21.76
(-0.41%)
USD 21.76
(-0.41%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -95.69 Million USD | 18.07% |
| 2022 | -116.79 Million USD | -0.32% |
| 2021 | -116.42 Million USD | -8.75% |
| 2020 | -107.05 Million USD | -141.79% |
| 2019 | -44.27 Million USD | 85.59% |
| 2018 | -307.3 Million USD | -574.58% |
| 2017 | -45.55 Million USD | 18.61% |
| 2016 | -55.97 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -87.86 Million USD | 31.85% |
| 2024 Q1 | -128.93 Million USD | -34.73% |
| 2024 Q3 | -86.78 Million USD | 1.24% |
| 2023 Q1 | -75 Million USD | 35.78% |
| 2023 Q2 | -99.04 Million USD | -32.06% |
| 2023 FY | -95.69 Million USD | 18.07% |
| 2023 Q3 | -104.86 Million USD | -5.87% |
| 2023 Q4 | -95.69 Million USD | 8.74% |
| 2022 Q2 | -89.69 Million USD | -54.86% |
| 2022 Q3 | -169.05 Million USD | -88.48% |
| 2022 FY | -116.79 Million USD | -0.32% |
| 2022 Q1 | -57.91 Million USD | 50.25% |
| 2022 Q4 | -116.79 Million USD | 30.91% |
| 2021 Q1 | -113.28 Million USD | -5.82% |
| 2021 FY | -116.42 Million USD | -8.75% |
| 2021 Q4 | -116.42 Million USD | 36.53% |
| 2021 Q3 | -183.43 Million USD | -13.36% |
| 2021 Q2 | -161.81 Million USD | -42.84% |
| 2020 Q2 | -121.63 Million USD | -16.85% |
| 2020 Q1 | -104.09 Million USD | -135.11% |
| 2020 FY | -107.05 Million USD | -141.79% |
| 2020 Q4 | -107.05 Million USD | -26.95% |
| 2020 Q3 | -84.32 Million USD | 30.67% |
| 2019 Q3 | -255.74 Million USD | 9.99% |
| 2019 FY | -44.27 Million USD | 85.59% |
| 2019 Q2 | -284.13 Million USD | 12.01% |
| 2019 Q1 | -322.91 Million USD | -5.08% |
| 2019 Q4 | -44.27 Million USD | 82.69% |
| 2018 Q1 | -221.1 Million USD | -385.36% |
| 2018 FY | -307.3 Million USD | -574.58% |
| 2018 Q2 | -285.51 Million USD | -29.13% |
| 2018 Q3 | -337.86 Million USD | -18.33% |
| 2018 Q4 | -307.3 Million USD | 9.04% |
| 2017 Q4 | -45.55 Million USD | 0.0% |
| 2017 Q1 | 55.97 Million USD | 0.0% |
| 2017 FY | -45.55 Million USD | 18.61% |
| 2016 FY | -55.97 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -71.069% |
| Novavax, Inc. | -298.29 Million USD | 67.919% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 105.118% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -4030.12% |
| Bicycle Therapeutics plc | -481.46 Million USD | 80.124% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 364.624% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -500.615% |
| Chimerix, Inc. | -25.51 Million USD | -275.028% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -304.173% |
| NextCure, Inc. | -6.47 Million USD | -1377.474% |
| Pharming Group N.V. | 109.8 Million USD | 187.152% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1038.656% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -1605.73% |
| Summit Therapeutics Inc. | 34.67 Million USD | 375.988% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 186.314% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -1159.821% |
| Lantern Pharma Inc. | -21.7 Million USD | -340.929% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 37.919% |
| Incyte Corporation | -3.17 Billion USD | 96.986% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -214.169% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 1893.067% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 653.86% |
| Alkermes plc | -166.73 Million USD | 42.607% |
| Aptorum Group Limited | 1.35 Million USD | 7151.787% |
| Ardelyx, Inc. | 34.51 Million USD | 377.283% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 2335.888% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 25.883% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 1487.985% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 60.515% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 13.426% |
| Immix Biopharma, Inc. | -17.5 Million USD | -446.529% |
| Jaguar Health, Inc. | 29.39 Million USD | 425.596% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 69.784% |
| MEI Pharma, Inc. | -3.7 Million USD | -2482.888% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 864.895% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 159.166% |
| Precision BioSciences, Inc. | -85.41 Million USD | -12.043% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 444.317% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -416.721% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 255.184% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1348.48% |
| Precigen, Inc. | -481 Thousand USD | -19795.218% |
| Senti Biosciences, Inc. | 1.74 Million USD | 5599.77% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 779.611% |
| ImmuCell Corporation | 10.99 Million USD | 970.711% |
| IO Biotech, Inc. | -140.69 Million USD | 31.985% |
| Agenus Inc. | 274.13 Million USD | 134.908% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -72.072% |
| ChromaDex Corporation | -24.04 Million USD | -297.937% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 1473.349% |
| CRISPR Therapeutics AG | -150.84 Million USD | 36.56% |
| Dyadic International, Inc. | -6.37 Million USD | -1400.384% |
| Elevation Oncology, Inc. | -19.11 Million USD | -400.554% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1348.48% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1020.145% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -1849.399% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -469.992% |
| ContextLogic Inc. | -232 Million USD | 58.752% |
| MiMedx Group, Inc. | -33.9 Million USD | -182.281% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -89.493% |
| Onconetix, Inc. | 5.33 Million USD | 1894.938% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -1400.172% |
| Opthea Limited | 28.15 Million USD | 439.86% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 886.762% |
| Vaxcyte, Inc. | -368.22 Million USD | 74.012% |
| PDS Biotechnology Corporation | -32.7 Million USD | -192.569% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -450.103% |
| PureTech Health plc | -167.19 Million USD | 42.765% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 45.388% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -416.721% |
| Seer, Inc. | -4.24 Million USD | -2156.981% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -1247.831% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -1533.038% |
| Acelyrin, Inc. | -216.9 Million USD | 55.881% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -5450.812% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1306.674% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 48.162% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -23.557% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -1478.621% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 96017.57% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 15338.217% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -298.12% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 18.241% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 43.117% |
| Innoviva, Inc. | 255.56 Million USD | 137.445% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -71.302% |
| ESSA Pharma Inc. | -33.62 Million USD | -184.627% |
| GlycoMimetics, Inc. | -40.98 Million USD | -133.494% |
| GT Biopharma, Inc. | -1.02 Million USD | -9272.772% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -41.18% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 256.221% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 28.627% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -590.647% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -231.449% |
| AlloVir, Inc. | -62.69 Million USD | -52.645% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -126928.964% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -210.077% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1067.757% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -2958.34% |
| Soligenix, Inc. | -4.95 Million USD | -1832.629% |
| Century Therapeutics, Inc. | 847 Thousand USD | 11398.229% |
| Kura Oncology, Inc. | -20.11 Million USD | -375.674% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -133.827% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1039.509% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 5353.13% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -2893.306% |
| Autolus Therapeutics plc | -186.59 Million USD | 48.716% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -94.094% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 65.302% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 379.258% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 158.221% |
| GRI Bio, Inc. | -1.79 Million USD | -5234.225% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -965.296% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -187.747% |
| IGM Biosciences, Inc. | -72.6 Million USD | -31.802% |
| INmune Bio, Inc. | -25.41 Million USD | -276.593% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 163.395% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -88.902% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -488.921% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -3217.104% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 351.732% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -132.356% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 400.129% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 125.32% |
| Verastem, Inc. | -37.27 Million USD | -156.709% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -954.734% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -84.52% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -532.283% |
| Histogen Inc. | -7.48 Million USD | -1178.162% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -342.897% |
| Surrozen, Inc. | -32.66 Million USD | -192.971% |
| Organovo Holdings, Inc. | -1.5 Million USD | -6250.1% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -2176.586% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 604.72% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 3758.104% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 2402.599% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1041.8% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -120.285% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -556.493% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 69.792% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -13153.192% |
| Apollomics, Inc. | -27.39 Million USD | -249.319% |
| Amarin Corporation plc | -191.04 Million USD | 49.908% |
| Mesoblast Limited | 55.96 Million USD | 270.999% |
| Turnstone Biologics Corp. | -14.58 Million USD | -556.171% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -278.365% |
| Synaptogenix, Inc. | -28.66 Million USD | -233.883% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -10123.932% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 296.372% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -11000.478% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1217.024% |
| Exelixis, Inc. | -73.05 Million USD | -31.001% |
| Better Therapeutics, Inc. | -860 Thousand USD | -11027.442% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -298.517% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 60.353% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 13101.008% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1186.559% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 7731.26% |
| Gritstone bio, Inc. | 39.49 Million USD | 342.33% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -13.787% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -3535.673% |
| Avid Bioservices, Inc. | 169.72 Million USD | 156.382% |
| Insmed Incorporated | 721.62 Million USD | 113.261% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -946.829% |
| MediWound Ltd. | -5.32 Million USD | -1698.121% |
| OmniAb, Inc. | 9.2 Million USD | 1139.835% |
| Alector, Inc. | -35.63 Million USD | -168.53% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 211.312% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -1841.883% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 822.834% |
| Zai Lab Limited | -775 Million USD | 87.652% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 128.1% |
| Aura Biosciences, Inc. | -21.52 Million USD | -344.581% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -16.023% |
| Immunic, Inc. | -45.34 Million USD | -111.063% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 50.472% |
| Veracyte, Inc. | -203.82 Million USD | 53.05% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 114.992% |
| FibroGen, Inc. | 56.76 Million USD | 268.577% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1174.632% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -3284.974% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -4522.218% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 102.085% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -2764.292% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 42.339% |
| TG Therapeutics, Inc. | 17.86 Million USD | 635.752% |
| Galecto, Inc. | -21.21 Million USD | -351.056% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -302.338% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 106.098% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -291.043% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -731.633% |
| XBiotech Inc. | -200.02 Million USD | 52.158% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -13.787% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 2213.428% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -171.378% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -23.93% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 1781.532% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 43.845% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -3.596% |
| Vaxxinity, Inc. | 10.13 Million USD | 1044.493% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 112.997% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -788.744% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -45.091% |
| NexImmune, Inc. | -3.13 Million USD | -2953.826% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -2671.65% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -533.268% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -253.122% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -966.126% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -76717.981% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -135.867% |
| Ainos, Inc. | 4.07 Million USD | 2446.682% |
| Pluri Inc. | 22.82 Million USD | 519.186% |
| Prothena Corporation plc | -608.34 Million USD | 84.27% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 19.418% |
| Celularity Inc. | 65.19 Million USD | 246.796% |
| Rallybio Corporation | -24.1 Million USD | -297.046% |
| Cue Biopharma, Inc. | -33.81 Million USD | -182.965% |
| MeiraGTx Holdings plc | -40.3 Million USD | -137.447% |
| Omeros Corporation | 331.17 Million USD | 128.896% |
| Humacyte, Inc. | -22.48 Million USD | -325.58% |
| Immunocore Holdings plc | -358.59 Million USD | 73.314% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -289.404% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -209.686% |
| Blueprint Medicines Corporation | 702.83 Million USD | 113.616% |
| CalciMedica, Inc. | -5.53 Million USD | -1630.488% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 49.157% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -836.91% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -139.019% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -187.782% |
| Pulmatrix, Inc. | -10.41 Million USD | -818.652% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -1501.071% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -150.894% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 14.098% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -59.642% |
| Cytokinetics, Incorporated | 642.37 Million USD | 114.897% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -1543.414% |
| Nutriband Inc. | -251.65 Thousand USD | -37926.361% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -180.477% |
| Vor Biopharma Inc. | 4.3 Million USD | 2325.488% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 98.415% |
| Evogene Ltd. | -19.63 Million USD | -387.399% |
| ProKidney Corp. | -56.23 Million USD | -70.169% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -96.614% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -935.986% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 107.016% |
| CorMedix Inc. | -43.05 Million USD | -122.277% |
| BioLineRx Ltd. | 7.33 Million USD | 1404.471% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -248.429% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 307.372% |
| Atai Life Sciences N.V. | -28.55 Million USD | -235.093% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 4390.283% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -319.425% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 639.588% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -27.469% |
| MediciNova, Inc. | -50.78 Million USD | -88.439% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -21.434% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -425310.091% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1383.064% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 52.109% |
| Biomea Fusion, Inc. | -166.57 Million USD | 42.549% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 46.531% |
| Mereo BioPharma Group plc | -51.46 Million USD | -85.929% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -0.898% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 67.424% |
| Absci Corporation | -72.59 Million USD | -31.816% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2195.839% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 59.181% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -1.576% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -144.916% |
| Allakos Inc. | -24.97 Million USD | -283.167% |
| Imunon, Inc. | -4.21 Million USD | -2170.986% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -549.139% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 29.323% |
| BioAtla, Inc. | -109.01 Million USD | 12.214% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 13101.008% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -10091.267% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 899.733% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -351.332% |
| XOMA Corporation | -29 Million USD | -229.986% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -477.874% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -961.402% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1184.683% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 23.22% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 54.029% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -17.018% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -3.162% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -11038.01% |
| Akari Therapeutics, Plc | -3.84 Million USD | -2388.843% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 5996.641% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 106.93% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -7954.304% |
| UroGen Pharma Ltd. | 4.39 Million USD | 2279.367% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 184.328% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 133081.296% |
| Orgenesis Inc. | 21.78 Million USD | 539.295% |
| Entera Bio Ltd. | -10.62 Million USD | -800.329% |
| GH Research PLC | -78.07 Million USD | -22.566% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -329.361% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -258.963% |
| Xencor, Inc. | 29.64 Million USD | 422.817% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -4758.129% |
| Replimune Group, Inc. | 1.41 Million USD | 6877.337% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -38974.265% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 24.301% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -7954.304% |
| Portage Biotech Inc. | -4.98 Million USD | -1821.221% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -425310.091% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -44.726% |
| OncoCyte Corporation | -6.56 Million USD | -1358.114% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 10763.541% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -2000.604% |
| Purple Biotech Ltd. | -14.13 Million USD | -576.871% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -302.829% |
| scPharmaceuticals Inc. | -6.54 Million USD | -1362.124% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -473.299% |
| HilleVax, Inc. | -165.48 Million USD | 42.172% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -3670.528% |
| Tharimmune, Inc. | -10.93 Million USD | -775.107% |
| Genprex, Inc. | -6.73 Million USD | -1320.322% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 74.053% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -8.18% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -6730.55% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -2785.064% |
| OKYO Pharma Limited | -826.84 Thousand USD | -11473.59% |
| Savara Inc. | 153 Thousand USD | 62646.405% |
| Curis, Inc. | -23.88 Million USD | -300.62% |
| Daré Bioscience, Inc. | -5.15 Million USD | -1755.325% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -12231.768% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -1441.495% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 8175.612% |
| BeiGene, Ltd. | -2.25 Billion USD | 95.753% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 875.589% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 84.266% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 48.436% |
| Erasca, Inc. | -37.21 Million USD | -157.137% |
| bluebird bio, Inc. | 108.57 Million USD | 188.141% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -7330.431% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 125.266% |
| DBV Technologies S.A. | -126.98 Million USD | 24.641% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -7330.431% |
| Moderna, Inc. | -2.9 Billion USD | 96.708% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -824.42% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -780.53% |
| Molecular Templates, Inc. | 707 Thousand USD | 13635.502% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -205.046% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 127.609% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -16.614% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -4.324% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -196.529% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -178.38% |
| MacroGenics, Inc. | -66.98 Million USD | -42.862% |
| RenovoRx, Inc. | -1.17 Million USD | -8058.227% |
| Adicet Bio, Inc. | -138.78 Million USD | 31.048% |
| Prime Medicine, Inc. | -27.94 Million USD | -242.493% |
| Aditxt, Inc. | 18.12 Million USD | 628.098% |
| Adagene Inc. | -87.62 Million USD | -9.208% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -2197.387% |
| Quantum-Si incorporated | -118.55 Million USD | 19.283% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 365.785% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1180.353% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -97.275% |
| SciSparc Ltd. | -2.06 Million USD | -4534.189% |
| Vericel Corporation | 1.27 Million USD | 7593.814% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -698.019% |
| Minerva Neurosciences, Inc. | 41 Million USD | 333.381% |
| Generation Bio Co. | 31.44 Million USD | 404.299% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 45.43% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -209.465% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 182.077% |
| Invivyd, Inc. | -198.47 Million USD | 51.785% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -6.011% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -3891.178% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -35.183% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -1302.139% |
| 2seventy bio, Inc. | 181.71 Million USD | 152.663% |
| ADMA Biologics, Inc. | 90.06 Million USD | 206.251% |
| Clene Inc. | 3.34 Million USD | 2965.15% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -953.607% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -344.87% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1383.064% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 72.191% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -268.066% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 153.863% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -2238.859% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 2013.155% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -1737.128% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 26.559% |
| Evaxion Biotech A/S | 5.28 Million USD | 1910.078% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 14.988% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 27.102% |
| Trevena, Inc. | 2.25 Million USD | 4338.087% |
| Surrozen, Inc. | -32.66 Million USD | -192.971% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -85.781% |
| Cingulate Inc. | 3.08 Million USD | 3204.309% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -3158.291% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 1431.515% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -929.961% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -20.641% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 27.201% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 9.329% |
| Clearmind Medicine Inc. | -3.94 Million USD | -2327.208% |
| Kronos Bio, Inc. | -36.05 Million USD | -165.424% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1117.069% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 6662.94% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -76.379% |
| Statera Biopharma, Inc. | 14.41 Million USD | 763.799% |
| ImmunityBio, Inc. | 618.22 Million USD | 115.479% |
| Korro Bio, Inc. | -132.94 Million USD | 28.017% |
| Kineta, Inc. | -4.54 Million USD | -2007.377% |
| BioVie Inc. | -17.73 Million USD | -439.669% |
| Codexis, Inc. | -43.27 Million USD | -121.155% |
| Celularity Inc. | 65.19 Million USD | 246.796% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -2919.754% |
| Celcuity Inc. | 6.78 Million USD | 1510.715% |
| Virax Biolabs Group Limited | -3.36 Million USD | -2743.911% |
| Cibus, Inc. | -8.07 Million USD | -1084.65% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -2162.852% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 2194.004% |
| IN8bio, Inc. | -16.38 Million USD | -483.904% |
| Kodiak Sciences Inc. | -103.87 Million USD | 7.874% |
| Annexon, Inc. | -193.75 Million USD | 50.61% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 265922.222% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -446.866% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -2624.054% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 109.077% |
| Eyenovia, Inc. | 1.25 Million USD | 7702.753% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 455.681% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -2850.848% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -187.833% |
| Arcellx, Inc. | -296.95 Million USD | 67.775% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -390.598% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -62.541% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -361.697% |
| Moolec Science SA | 117.61 Thousand USD | 81463.08% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -149.215% |
| Geron Corporation | 14.76 Million USD | 748.303% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -152.376% |
| Royalty Pharma plc | 5.65 Billion USD | 101.691% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 32.333% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -1269.154% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -1684.421% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 32.001% |
| Humacyte, Inc. | -22.48 Million USD | -325.58% |
| Structure Therapeutics Inc. | -124.33 Million USD | 23.036% |
| 89bio, Inc. | -289.05 Million USD | 66.893% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -279.114% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -5267.134% |
| Genelux Corporation | -6.89 Million USD | -1287.1% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -208.11% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 214.47% |
| Notable Labs, Ltd. | -9.77 Million USD | -878.887% |
| Liquidia Corporation | -80.17 Million USD | -19.357% |
| Mustang Bio, Inc. | -3.73 Million USD | -2461.456% |
| Immunovant, Inc. | -635.22 Million USD | 84.935% |
| Quantum-Si incorporated | -118.55 Million USD | 19.283% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -444.842% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -2209.824% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1292.176% |
| Acasti Pharma Inc. | -23 Million USD | -315.979% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -2741.981% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -488.921% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 30.524% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -2970.76% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -330.443% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -415.354% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 43.468% |
| PepGen Inc. | -60.67 Million USD | -57.732% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -316.504% |
| United Therapeutics Corporation | -507.7 Million USD | 81.151% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -400.345% |
| Solid Biosciences Inc. | -47.75 Million USD | -100.41% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -11000.478% |
| Immuneering Corporation | -54.94 Million USD | -74.174% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -2176.586% |
| Silo Pharma, Inc. | -3.52 Million USD | -2615.313% |
| Belite Bio, Inc | -87.27 Million USD | -9.654% |
| XOMA Corporation | -29 Million USD | -229.986% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -35.361% |
| Bionomics Limited | 227 Million USD | 142.155% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 17.704% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -3677.971% |
| uniQure N.V. | -102.95 Million USD | 7.047% |
| Cassava Sciences, Inc. | -121.13 Million USD | 21.001% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -2197.387% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 333.684% |
| Forte Biosciences, Inc. | -11.96 Million USD | -700.067% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -2992.754% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 90379.245% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -2850.848% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1174.632% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1190.399% |
| Altimmune, Inc. | -134.48 Million USD | 28.844% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 148.315% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -3677.971% |
| Compugen Ltd. | -12.9 Million USD | -641.6% |
| Peak Bio, Inc. | 10.34 Million USD | 1025.479% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -33714.841% |
| Benitec Biopharma Inc. | -50.58 Million USD | -89.19% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 8.283% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 587.126% |
| Zura Bio Limited | -99.8 Million USD | 4.118% |
| PolyPid Ltd. | 6.17 Million USD | 1650.989% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 229.11% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 587.126% |
| Instil Bio, Inc. | 75.35 Million USD | 226.989% |
| argenx SE | -2.02 Billion USD | 95.283% |
| Immunome, Inc. | -97.02 Million USD | 1.374% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -325.41% |
| Verona Pharma plc | -220.44 Million USD | 56.589% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -33.387% |
| Shattuck Labs, Inc. | -121.42 Million USD | 21.189% |
| CervoMed Inc. | -7.79 Million USD | -1127.998% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 48.412% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -2088.338% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 27.36% |
| Moolec Science SA | 117.61 Thousand USD | 81463.08% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -4082.56% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 701.923% |
| AnaptysBio, Inc. | -18.15 Million USD | -427.222% |
| Design Therapeutics, Inc. | -18.15 Million USD | -427.251% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -35.969% |
| NeurAxis, Inc. | 145.7 Thousand USD | 65780.165% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 951.994% |
| Lumos Pharma, Inc. | -28.49 Million USD | -235.858% |
| Achilles Therapeutics plc | -126.92 Million USD | 24.604% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -33.387% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -14493.811% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -360.657% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 6662.94% |
| Nutriband Inc. | -251.65 Thousand USD | -37926.361% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -626.566% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1186.237% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 128.13% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 503.185% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 78.614% |
| Palisade Bio, Inc. | -12.06 Million USD | -693.302% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 31.797% |
| Beam Therapeutics Inc. | -262.72 Million USD | 63.575% |
| Neurogene Inc. | -131.95 Million USD | 27.478% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 538.651% |
| AEON Biopharma, Inc. | -4.88 Million USD | -1860.984% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 74.629% |
| Sesen Bio, Inc. | -112.55 Million USD | 14.977% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 4.17% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -3975.998% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -145.211% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -14.906% |
| Athira Pharma, Inc. | -88.99 Million USD | -7.525% |
| Vaccinex, Inc. | -1.28 Million USD | -7329.814% |
| HCW Biologics Inc. | 2.85 Million USD | 3449.907% |
| XOMA Corporation | -29 Million USD | -229.986% |
| Nektar Therapeutics | 210.24 Million USD | 145.518% |
| Arvinas, Inc. | -313.8 Million USD | 69.504% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 5996.641% |
| Merus N.V. | -192.88 Million USD | 50.387% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 259.533% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -1279.302% |
| Rezolute, Inc. | -68.16 Million USD | -40.383% |
| Clene Inc. | 3.34 Million USD | 2965.15% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -625.684% |
| BeyondSpring Inc. | -13.75 Million USD | -595.718% |
| Synlogic, Inc. | -6.68 Million USD | -1331.503% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 8538.801% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1031.827% |
| Peak Bio, Inc. | 10.34 Million USD | 1025.479% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -16.108% |
| Krystal Biotech, Inc. | -350.23 Million USD | 72.677% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 177.096% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 43.374% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -2931.094% |
| MannKind Corporation | 143.89 Million USD | 166.502% |
| Ikena Oncology, Inc. | -109.15 Million USD | 12.331% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1163.981% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -189.112% |
| Gossamer Bio, Inc. | 180.35 Million USD | 153.06% |
| CohBar, Inc. | -5.93 Million USD | -1513.562% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -221.689% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2195.839% |
| Legend Biotech Corporation | -949.39 Million USD | 89.92% |
| Mural Oncology plc | -255.84 Million USD | 62.596% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 397.054% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -1931.485% |
| Disc Medicine, Inc. | -358.28 Million USD | 73.29% |
| Champions Oncology, Inc. | 4.81 Million USD | 2088.695% |
| REGENXBIO Inc. | 54.76 Million USD | 274.73% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -35487.025% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 36.635% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -961.872% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -18.607% |
| Vaxart, Inc. | -8.24 Million USD | -1061.218% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -90.706% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 24.747% |
| Cellectis S.A. | -43.85 Million USD | -118.21% |
| Longeveron Inc. | -2.9 Million USD | -3190.784% |
| Repare Therapeutics Inc. | -107.85 Million USD | 11.276% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 109.882% |
| Inozyme Pharma, Inc. | 12 Million USD | 897.201% |
| Revolution Medicines, Inc. | -608.2 Million USD | 84.266% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -7680.163% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 63.904% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 36.233% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -511.593% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -12831.892% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.999% |
| Denali Therapeutics Inc. | -74.86 Million USD | -27.825% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -698.019% |
| Veru Inc. | 4.77 Million USD | 2102.021% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -750.934% |
| Cingulate Inc. | 3.08 Million USD | 3204.309% |
| Passage Bio, Inc. | 4.58 Million USD | 2187.154% |
| Context Therapeutics Inc. | -14.44 Million USD | -562.264% |
| Exicure, Inc. | 5.84 Million USD | 1736.109% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 58.461% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -141.84% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 709.878% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -62.69% |
| Nuvalent, Inc. | -335.38 Million USD | 71.467% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 5617.715% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -28.482% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -976.445% |
| OmniAb, Inc. | 9.2 Million USD | 1139.835% |
| Anew Medical, Inc. | 1.43 Million USD | 6780.512% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 684.162% |
| Lipocine Inc. | -4.75 Million USD | -1912.707% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 12.867% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 728.298% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -88.902% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 484.445% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1323.836% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -45.375% |
| Ocugen, Inc. | -32.52 Million USD | -194.259% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -11.827% |
| Q32 Bio Inc. | -37.94 Million USD | -152.177% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -15138.217% |
| Alumis Inc. Common Stock | -13.52 Million USD | -607.34% |
| Equillium, Inc. | -22.39 Million USD | -327.367% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -274.28% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -193.305% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -38500.327% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 171.393% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 3092.37% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 29236.435% |
| Dominari Holdings Inc. | 195 Thousand USD | 49174.872% |
| Edesa Biotech, Inc. | -5.26 Million USD | -1716.929% |
| vTv Therapeutics Inc. | -8.91 Million USD | -973.186% |
| Bio-Techne Corporation | 267.74 Million USD | 135.741% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -490.388% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 18.966% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1038.831% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -656.43% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 60.959% |
| Nkarta, Inc. | 57.29 Million USD | 267.012% |
| BioCardia, Inc. | 212 Thousand USD | 45239.623% |
| Iterum Therapeutics plc | 13.43 Million USD | 812.13% |